Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT05744102
Starting soon Not applicable

Improve MRI Diagnosis

NCT05744102 · tracked via the Priya Life Science France tracker
Sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Not applicable
Started
2023-03-15
Last updated
2023-02-24

Condition(s) studied

New MRI Techniques

Investigational drug(s) / intervention(s)

MRI Image

MRI Image: MRI sequences

Study summary

The main objective of the research is to compare by two blind evaluators new MRI techniques with routinely used sequences.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Adult patient * Patient who signed a consent to participate in the study * Affiliated patient or beneficiary of a social security scheme * Patient having an MRI scheduled as part of their care pathway * Absence of prohibition of participation in another research Exclusion Criteria: * Patients under guardianship or curators * Pregnant or breastfeeding patients * Patients responding to a contraindication to performing an MRI * Patient under state medical aid (AME) * Adult patients protected by law

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHU Paul Brousse Villejuif France

More Assistance Publique - Hôpitaux de Paris trials in France

Molecular Signature From Tumor to Lymph Nodes Recruiting
Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis. Recruiting
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism Recruiting
Workshops and Exchange Groups for Laryngectomized Patients Recruiting
Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05744102 on ClinicalTrials.gov ↗ ← All trials in France